Item 4 — Purpose of Transaction
Item 4 of the Current Schedule 13D is hereby amended and supplemented to add the following: As disclosed in Amendment No. 3, on November 24, 2025, the Reporting Person submitted a non-binding proposal (the "Proposal") to the board of directors of the Issuer to acquire all of the issued and outstanding Shares not already owned by the Reporting Person for a cash consideration of US$20.60 per share (the "Proposed Transaction"). A copy of the Proposal was attached as Exhibit C to Amendment No. 3 and is incorporated herein by reference. The Proposed Transaction would result in one or more of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D, including an extraordinary corporate transaction involving the Issuer, a change in the present board of directors or management of the Issuer, the termination of the registration of the Shares under the Securities Act of 1934 and the delisting of a class of securities of the Issuer from the New York Stock Exchange. The Reporting Person may, at any time and from time to time, formulate other plans or proposals regarding the Issuer and the Shares, or any other actions that could involve one or more of the types of transactions or have one or more of the results described in paragraphs (a) through (j) of Item 4 of Schedule 13D. On January 8, 2026, pursuant to a letter from the Issuer's Board of Directors (the "Genco January 8th Response Letter"), the Reporting Person was notified that the Board of Directors of the Issuer had rejected the Proposal. A copy of the Genco January 8th Response Letter is attached as Exhibit E to this Amendment and is incorporated herein by reference. On January 13, 2026, the Reporting Person issued a Press Release in response to the Genco January 8th Response Letter, which is attached as Exhibit F to this Amendment and incorporated herein by reference.